# A First-in-Human Study of FID-022 in Solid Tumor Patients

> **NCT07249775** · — · RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 120 (estimated)

## Conditions studied

- Pancreatic Cancer
- Cancer Cachexia

## Interventions

- **OTHER:** Baseline Lifestyle and Symptom Assessment
- **OTHER:** Extended Lifestyle Monitoring
- **OTHER:** Feasibility Survey

## Key facts

- **NCT ID:** NCT07249775
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-08
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07249775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07249775, "A First-in-Human Study of FID-022 in Solid Tumor Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07249775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*